EDT — Spectral Medical Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$133.75m
- CA$139.36m
- CA$1.60m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -4.86 | -9.1 | -8.79 | -11.3 | -15.7 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.722 | 1.08 | 1.55 | 0.391 | 5.13 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.12 | 7.39 | -1.76 | 0.659 | -0.406 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -2.74 | -0.324 | -8.7 | -9.93 | -10.7 |
Capital Expenditures | -0.161 | -0.315 | -0.483 | -0.033 | -0.185 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | 0.018 | 0.158 | 0 | — |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -0.161 | -0.297 | -0.325 | -0.033 | -0.185 |
Financing Cash Flow Items | 0 | -0.786 | -1.13 | -1.33 | 1.51 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.023 | 5.18 | 12.2 | 9.48 | 5.44 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -2.93 | 4.37 | 3.08 | -0.476 | -5.46 |